id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-N-0475-0035,FDA,FDA-2007-N-0475,"FDA/OC  to Parties, from the Office of the Commissioner,  December 15, 2011 - Letter",Other,Letter(s),2011-12-22T05:00:00Z,2011,12,2011-12-22T05:00:00Z,,2011-12-22T18:45:27Z,,0,0,0900006480f88195
FDA-2007-N-0475-0034,FDA,FDA-2007-N-0475,"FDA/CDER and Shire Development, Inc. to Margaret A. Hamburg, M.D., FDA Commissioner - Propose to Hold in Abeyance CDER's August 16, 2010 Notice of Opportunity for Hearing - Memo",Other,Memo,2011-12-06T05:00:00Z,2011,12,2011-12-06T05:00:00Z,,2011-12-06T14:44:31Z,,0,0,0900006480f7c4c2
FDA-2007-N-0475-0033,FDA,FDA-2007-N-0475,"FDA/Office of the Commissioner Response to the Parties re: Process, October 13, 2011 - Letter",Other,Letter(s),2011-10-13T04:00:00Z,2011,10,2011-10-13T04:00:00Z,,2011-10-13T15:54:07Z,,0,0,0900006480f516a4